Dr. Amiel Tokayer, M.D.
What this data tells you about Dr. Tokayer
Dr. Amiel Tokayer is a rheumatology in Boynton Beach, FL, with 20 years in practice. Based on federal Medicare data, Dr. Tokayer performed 219,394 Medicare services across 3,840 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tokayer received a total of $62,188 from 54 pharmaceutical and/or device companies across 1407 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tokayer is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 61,162 | $5 | $9 |
| Romosozumab injection (Evenity) for osteoporosis | 42,848 | $8 | $13 |
| Certolizumab injection (Cimzia) | 41,400 | $4 | $14 |
| Denosumab injection (Prolia/Xgeva) | 39,362 | $18 | $28 |
| Abatacept infusion (Orencia) | 10,800 | $34 | $62 |
| Golimumab infusion (Simponi Aria) | 8,650 | $11 | $35 |
| Joint lubricant injection (GenVisc) | 4,200 | $5 | $20 |
| Infliximab infusion (Remicade) | 2,150 | $26 | $57 |
| Injection, rituximab, 10 mg | 1,750 | $64 | $110 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 1,077 | $59 | $95 |
| Office visit, established patient (30-39 min) | 1,048 | $97 | $155 |
| Injection, methylprednisolone acetate, 40 mg | 985 | $6 | $10 |
| Steroid injection (triamcinolone) | 636 | $1 | $5 |
| Joint injection, major joint | 551 | $44 | $109 |
| Office visit, established patient (20-29 min) | 431 | $69 | $110 |
| Administration of chemotherapy into vein, 1 hour or less | 403 | $106 | $200 |
| Injection, zoledronic acid, 1 mg | 221 | $6 | $20 |
| Injection of trigger points, 1-2 muscles | 212 | $35 | $84 |
| Aspiration and/or injection of fluid from small joint | 201 | $29 | $83 |
| New patient office visit (45-59 min) | 173 | $125 | $210 |
| Betamethasone steroid injection | 133 | $5 | $10 |
| X-ray of hand, minimum of 3 views | 120 | $26 | $67 |
| Injection into tendon or ligament | 109 | $37 | $105 |
| Administration of chemotherapy into vein, each additional hour | 100 | $23 | $85 |
| Office visit, established patient, complex (40-54 min) | 68 | $138 | $225 |
| X-ray of lower and sacral spine, 2-3 views | 65 | $29 | $68 |
| Injection of trigger points, 3 or more muscles | 58 | $46 | $95 |
| New patient office visit, complex (60-74 min) | 51 | $162 | $267 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 45 | $48 | $100 |
| Drug injection, under skin or into muscle | 45 | $11 | $35 |
| Knee X-ray, 3 views | 44 | $31 | $60 |
| Shoulder X-ray, 2+ views | 38 | $26 | $65 |
| Injection of additional new drug or substance into vein | 35 | $13 | $45 |
| Aspiration and/or injection of fluid from medium joint | 33 | $35 | $90 |
| Injection of anesthetic agent and/or steroid into lower back and leg nerve (sciatic nerve) | 29 | $129 | $245 |
| Injection, methylprednisolone sodium succinate, up to 125 mg | 27 | $4 | $10 |
| Complete ultrasound scan of joint | 26 | $8 | $150 |
| Hip X-ray, 2-3 views | 25 | $34 | $61 |
| New patient office visit (30-44 min) | 24 | $81 | $150 |
| X-ray of upper spine, 4-5 views | 19 | $38 | $90 |
| Injection of carpal tunnel | 15 | $64 | $175 |
| X-ray of pelvis, 1-2 views | 13 | $21 | $58 |
| X-ray of middle spine, 2 views | 12 | $25 | $68 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (58%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers.
Geographic Context
3.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Tokayer is a mixed practice specialist, with above-average Medicare volume (top 8% in FL), and high industry engagement (consulting-driven, top 11%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Tokayer experienced with tocilizumab injection (actemra)?
Does Dr. Tokayer receive payments from pharmaceutical companies?
How do Dr. Tokayer's costs compare to other rheumatologys in Boynton Beach?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology